Skip to main content
Fig. 2 | BMC Bioinformatics

Fig. 2

From: High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer: an analysis based on public databases

Fig. 2

Identification of prognostic cuproptosis-related genes in breast cancer. A 4 cuproptosis-related genes, DLAT, SLC31A1, ATP7A and ATP7B, were correlated with prognosis of breast cancer patients. B Expression of SLC31A1 in tumor samples was higher than that in normal samples in breast cancer. C For each patient, tumor tissues generally showed higher expression levels of SLC31A1 than normal tissues, based on data from TCGA database. Y-axis represents log2 (TPM) values of SLC31A1 expression of samples. D Pan-cancer expression analysis of SLC31A1 between normal and tumor samples according to TIMER. BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma; ESCA, esophageal carcinoma; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; PCPG, pheochromocytoma and paraganglioma; STAD, stomach adenocarcinoma; UCEC, uterine corpus endometrial carcinoma; CHOL, cholangiocarcinoma; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LUSC, lung squamous cell carcinoma; prostate adenocarcinoma; THCA, thyroid carcinoma; *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page

BMC Bioinformatics

ISSN: 1471-2105

Contact us